人类免疫缺陷病毒1型逆转录酶与逆转录早期事件。 - Suppr

Suppr

超能文献

Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription.

作者信息

Arts E J, Wainberg M A

机构信息

McGill University AIDS Centre, Sir Mortimer B. Davis-Jewish General Hospital, Montréal, Québec, Canada.

出版信息

Adv Virus Res. 1996;46:97-163. doi: 10.1016/s0065-3527(08)60071-8.

DOI:10.1016/s0065-3527(08)60071-8

PMID:8824699

Abstract

摘要

相似文献

Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription.

Adv Virus Res. 1996;46:97-163. doi: 10.1016/s0065-3527(08)60071-8.

Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I.

Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5694-8. doi: 10.1073/pnas.92.12.5694.

Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase.

Biochemistry. 1995 Apr 25;34(16):5351-63. doi: 10.1021/bi00016a006.

Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates.

Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6919-23. doi: 10.1073/pnas.89.15.6919.

Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection.

Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6125-9. doi: 10.1073/pnas.90.13.6125.

HIV-1 reverse transcription. A termination step at the center of the genome.

J Mol Biol. 1994 Sep 2;241(5):651-62. doi: 10.1006/jmbi.1994.1542.

Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends.

Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):549-53. doi: 10.1073/pnas.91.2.549.

Circularization of the HIV-1 genome facilitates strand transfer during reverse transcription.

RNA. 2010 Jun;16(6):1226-35. doi: 10.1261/rna.2039610. Epub 2010 Apr 29.

Efficient extension of a misaligned tRNA-primer during replication of the HIV-1 retrovirus.

Nucleic Acids Res. 1995 Apr 25;23(8):1319-26. doi: 10.1093/nar/23.8.1319.

In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription.

Nucleic Acids Res. 1992 Nov 25;20(22):5999-6006. doi: 10.1093/nar/20.22.5999.

引用本文的文献

The nucleic acid chaperone activity of the HIV-1 Gag polyprotein is boosted by its cellular partner RPL7: a kinetic study.

Nucleic Acids Res. 2020 Sep 18;48(16):9218-9234. doi: 10.1093/nar/gkaa659.

Positional adaptability in the design of mutation-resistant nonnucleoside HIV-1 reverse transcriptase inhibitors: a supramolecular perspective.

AIDS Res Hum Retroviruses. 2013 Jan;29(1):4-12. doi: 10.1089/AID.2012.0141. Epub 2012 Oct 4.

Early events of HIV-1 infection: can signaling be the next therapeutic target?

J Neuroimmune Pharmacol. 2011 Jun;6(2):269-83. doi: 10.1007/s11481-011-9268-5. Epub 2011 Mar 5.

Human TOP1 residues implicated in species specificity of HIV-1 infection are required for interaction with BTBD2, and RNAi of BTBD2 in old world monkey and human cells increases permissiveness to HIV-1 infection.

Virol J. 2010 Nov 20;7:332. doi: 10.1186/1743-422X-7-332.

Reduced fitness in cell culture of HIV-1 with nonnucleoside reverse transcriptase inhibitor-resistant mutations correlates with relative levels of reverse transcriptase content and RNase H activity in virions.

J Virol. 2010 Sep;84(18):9377-89. doi: 10.1128/JVI.00618-10. Epub 2010 Jun 30.

Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection.

Proc Natl Acad Sci U S A. 2006 May 9;103(19):7454-9. doi: 10.1073/pnas.0600771103. Epub 2006 Apr 28.

The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates.

J Virol. 2005 May;79(10):6111-21. doi: 10.1128/JVI.79.10.6111-6121.2005.

Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.

J Virol. 2005 Apr;79(7):3930-7. doi: 10.1128/JVI.79.7.3930-3937.2005.

Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.

J Virol. 2005 Mar;79(5):3139-45. doi: 10.1128/JVI.79.5.3139-3145.2005.

Diversity-oriented solid-phase synthesis and biological evaluation of oligonucleotide hairpins as HIV-1 RT RNase H inhibitors.

Nucleic Acids Res. 2004 Nov 29;32(21):6164-75. doi: 10.1093/nar/gkh948. Print 2004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription.

作者信息

Arts E J, Wainberg M A

机构信息

McGill University AIDS Centre, Sir Mortimer B. Davis-Jewish General Hospital, Montréal, Québec, Canada.

出版信息

Adv Virus Res. 1996;46:97-163. doi: 10.1016/s0065-3527(08)60071-8.

DOI:10.1016/s0065-3527(08)60071-8

PMID:8824699

Abstract

摘要

相似文献

Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription.

Adv Virus Res. 1996;46:97-163. doi: 10.1016/s0065-3527(08)60071-8.

Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I.

Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5694-8. doi: 10.1073/pnas.92.12.5694.

Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase.

Biochemistry. 1995 Apr 25;34(16):5351-63. doi: 10.1021/bi00016a006.

Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates.

Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6919-23. doi: 10.1073/pnas.89.15.6919.

Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection.

Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6125-9. doi: 10.1073/pnas.90.13.6125.

HIV-1 reverse transcription. A termination step at the center of the genome.

J Mol Biol. 1994 Sep 2;241(5):651-62. doi: 10.1006/jmbi.1994.1542.

Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends.

Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):549-53. doi: 10.1073/pnas.91.2.549.

Circularization of the HIV-1 genome facilitates strand transfer during reverse transcription.

RNA. 2010 Jun;16(6):1226-35. doi: 10.1261/rna.2039610. Epub 2010 Apr 29.

Efficient extension of a misaligned tRNA-primer during replication of the HIV-1 retrovirus.

Nucleic Acids Res. 1995 Apr 25;23(8):1319-26. doi: 10.1093/nar/23.8.1319.

In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription.

Nucleic Acids Res. 1992 Nov 25;20(22):5999-6006. doi: 10.1093/nar/20.22.5999.

引用本文的文献

The nucleic acid chaperone activity of the HIV-1 Gag polyprotein is boosted by its cellular partner RPL7: a kinetic study.

Nucleic Acids Res. 2020 Sep 18;48(16):9218-9234. doi: 10.1093/nar/gkaa659.

Positional adaptability in the design of mutation-resistant nonnucleoside HIV-1 reverse transcriptase inhibitors: a supramolecular perspective.

AIDS Res Hum Retroviruses. 2013 Jan;29(1):4-12. doi: 10.1089/AID.2012.0141. Epub 2012 Oct 4.

Early events of HIV-1 infection: can signaling be the next therapeutic target?

J Neuroimmune Pharmacol. 2011 Jun;6(2):269-83. doi: 10.1007/s11481-011-9268-5. Epub 2011 Mar 5.

Virol J. 2010 Nov 20;7:332. doi: 10.1186/1743-422X-7-332.

J Virol. 2010 Sep;84(18):9377-89. doi: 10.1128/JVI.00618-10. Epub 2010 Jun 30.

Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection.

Proc Natl Acad Sci U S A. 2006 May 9;103(19):7454-9. doi: 10.1073/pnas.0600771103. Epub 2006 Apr 28.

The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates.

J Virol. 2005 May;79(10):6111-21. doi: 10.1128/JVI.79.10.6111-6121.2005.

Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.

J Virol. 2005 Apr;79(7):3930-7. doi: 10.1128/JVI.79.7.3930-3937.2005.

Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.

J Virol. 2005 Mar;79(5):3139-45. doi: 10.1128/JVI.79.5.3139-3145.2005.

Diversity-oriented solid-phase synthesis and biological evaluation of oligonucleotide hairpins as HIV-1 RT RNase H inhibitors.

Nucleic Acids Res. 2004 Nov 29;32(21):6164-75. doi: 10.1093/nar/gkh948. Print 2004.